285 related articles for article (PubMed ID: 25305317)
21. Selection of escape mutant by HLA-C-restricted HIV-1 Pol-specific cytotoxic T lymphocytes carrying strong ability to suppress HIV-1 replication.
Honda K; Zheng N; Murakoshi H; Hashimoto M; Sakai K; Borghan MA; Chikata T; Koyanagi M; Tamura Y; Gatanaga H; Oka S; Takiguchi M
Eur J Immunol; 2011 Jan; 41(1):97-106. PubMed ID: 21182081
[TBL] [Abstract][Full Text] [Related]
22. CTL recognition of HIV-1-infected cells via cross-recognition of multiple overlapping peptides from a single 11-mer Pol sequence.
Hashimoto M; Akahoshi T; Murakoshi H; Ishizuka N; Oka S; Takiguchi M
Eur J Immunol; 2012 Oct; 42(10):2621-31. PubMed ID: 22740036
[TBL] [Abstract][Full Text] [Related]
23. Identification of cross-clade CTL epitopes in HIV-1 clade A/E-infected individuals by using the clade B overlapping peptides.
Watanabe K; Murakoshi H; Tamura Y; Koyanagi M; Chikata T; Gatanaga H; Oka S; Takiguchi M
Microbes Infect; 2013 Nov; 15(13):874-86. PubMed ID: 23968885
[TBL] [Abstract][Full Text] [Related]
24. Multilayered defense in HLA-B51-associated HIV viral control.
Zhang Y; Peng Y; Yan H; Xu K; Saito M; Wu H; Chen X; Ranasinghe S; Kuse N; Powell T; Zhao Y; Li W; Zhang X; Feng X; Li N; Leligdowicz A; Xu X; John M; Takiguchi M; McMichael A; Rowland-Jones S; Dong T
J Immunol; 2011 Jul; 187(2):684-91. PubMed ID: 21670313
[TBL] [Abstract][Full Text] [Related]
25. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
[TBL] [Abstract][Full Text] [Related]
26. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
[TBL] [Abstract][Full Text] [Related]
27. HIV evolution: CTL escape mutation and reversion after transmission.
Leslie AJ; Pfafferott KJ; Chetty P; Draenert R; Addo MM; Feeney M; Tang Y; Holmes EC; Allen T; Prado JG; Altfeld M; Brander C; Dixon C; Ramduth D; Jeena P; Thomas SA; St John A; Roach TA; Kupfer B; Luzzi G; Edwards A; Taylor G; Lyall H; Tudor-Williams G; Novelli V; Martinez-Picado J; Kiepiela P; Walker BD; Goulder PJ
Nat Med; 2004 Mar; 10(3):282-9. PubMed ID: 14770175
[TBL] [Abstract][Full Text] [Related]
28. T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily.
Lichterfeld M; Williams KL; Mui SK; Shah SS; Mothe BR; Sette A; Kim A; Johnston MN; Burgett N; Frahm N; Cohen D; Brander C; Rosenberg ES; Walker BD; Altfeld M; Yu XG
Int Immunol; 2006 Jul; 18(7):1179-88. PubMed ID: 16772368
[TBL] [Abstract][Full Text] [Related]
29. Different abilities of escape mutant-specific cytotoxic T cells to suppress replication of escape mutant and wild-type human immunodeficiency virus type 1 in new hosts.
Fujiwara M; Tanuma J; Koizumi H; Kawashima Y; Honda K; Mastuoka-Aizawa S; Dohki S; Oka S; Takiguchi M
J Virol; 2008 Jan; 82(1):138-47. PubMed ID: 17959671
[TBL] [Abstract][Full Text] [Related]
30. HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control.
Kloverpris HN; Stryhn A; Harndahl M; van der Stok M; Payne RP; Matthews PC; Chen F; Riddell L; Walker BD; Ndung'u T; Buus S; Goulder P
J Virol; 2012 Jan; 86(2):919-29. PubMed ID: 22090105
[TBL] [Abstract][Full Text] [Related]
31. Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic.
Schellens IM; Navis M; van Deutekom HW; Boeser-Nunnink B; Berkhout B; Kootstra N; Miedema F; Keşmir C; Schuitemaker H; van Baarle D; Borghans JA
AIDS; 2011 Sep; 25(14):1691-700. PubMed ID: 21681058
[TBL] [Abstract][Full Text] [Related]
32. Control of HIV-1 by an HLA-B*52:01-C*12:02 Protective Haplotype.
Chikata T; Murakoshi H; Koyanagi M; Honda K; Gatanaga H; Oka S; Takiguchi M
J Infect Dis; 2017 Dec; 216(11):1415-1424. PubMed ID: 28968792
[TBL] [Abstract][Full Text] [Related]
33. Different in vivo effects of HIV-1 immunodominant epitope-specific cytotoxic T lymphocytes on selection of escape mutant viruses.
Koizumi H; Hashimoto M; Fujiwara M; Murakoshi H; Chikata T; Borghan MA; Hachiya A; Kawashima Y; Takata H; Ueno T; Oka S; Takiguchi M
J Virol; 2010 Jun; 84(11):5508-19. PubMed ID: 20335254
[TBL] [Abstract][Full Text] [Related]
34. Selection of HLA-B57-associated Gag A146P mutant by HLA-B∗48:01-restricted Gag140-147-specific CTLs in chronically HIV-1-infected Japanese.
Naruto T; Murakoshi H; Chikata T; Koyanagi M; Kawashima Y; Gatanaga H; Oka S; Takiguchi M
Microbes Infect; 2011 Aug; 13(8-9):766-70. PubMed ID: 21473930
[TBL] [Abstract][Full Text] [Related]
35. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
[TBL] [Abstract][Full Text] [Related]
36. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.
Bailey JR; Williams TM; Siliciano RF; Blankson JN
J Exp Med; 2006 May; 203(5):1357-69. PubMed ID: 16682496
[TBL] [Abstract][Full Text] [Related]
37. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
Altfeld M; Addo MM; Rosenberg ES; Hecht FM; Lee PK; Vogel M; Yu XG; Draenert R; Johnston MN; Strick D; Allen TM; Feeney ME; Kahn JO; Sekaly RP; Levy JA; Rockstroh JK; Goulder PJ; Walker BD
AIDS; 2003 Dec; 17(18):2581-91. PubMed ID: 14685052
[TBL] [Abstract][Full Text] [Related]
38. Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children.
Buseyne F; Chaix ML; Rouzioux C; Blanche S; Rivière Y
J Virol; 2001 May; 75(10):4941-6. PubMed ID: 11312369
[TBL] [Abstract][Full Text] [Related]
39. Naturally selected rilpivirine-resistant HIV-1 variants by host cellular immunity.
Gatanaga H; Murakoshi H; Hachiya A; Hayashida T; Chikata T; Ode H; Tsuchiya K; Sugiura W; Takiguchi M; Oka S
Clin Infect Dis; 2013 Oct; 57(7):1051-5. PubMed ID: 23797286
[TBL] [Abstract][Full Text] [Related]
40. Broad Recognition of Circulating HIV-1 by HIV-1-Specific Cytotoxic T-Lymphocytes with Strong Ability to Suppress HIV-1 Replication.
Murakoshi H; Kuse N; Akahoshi T; Zhang Y; Chikata T; Borghan MA; Gatanaga H; Oka S; Sakai K; Takiguchi M
J Virol; 2019 Jan; 93(1):. PubMed ID: 30333175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
